Editor

8390 POSTS
0 COMMENTS

Sturdy Gleevec Profit Doubles Survival in Superior GIST

Lengthy-term follow-up of the BFR14 trial confirmed that Gleevec (imatinib) stays efficient in superior gastrointestinal stromal tumors (GIST), with sufferers reaching full...

Lenvima Combo Fails to Lengthen Survival in Esophageal Most cancers

The mixture of Lenvima (lenvatinib) and Keytruda (pembrolizumab) with chemotherapy didn't assist sufferers with metastatic esophageal squamous cell carcinoma stay longer in...

Imfinzi Not Related With Bladder Most cancers High quality of Life Decline

Amongst sufferers with muscle-invasive bladder most cancers, the addition of perioperative Imfinzi (durvalumab), which means it's administered earlier than and after surgical...

Imfinzi Plus Chemo Improves Survival in G/GEJ Adenocarcinoma

Amongst sufferers with gastric/gastroesophageal junction (G/GEJ) adenocarcinoma that's resectable, or detachable by surgical procedure the mixture of the anti-PD-L1 monoclonal antibody Imfinzi...

Tagrisso Plus Chemo Provides Survival profit in EGFR+ NSCLC

Amongst sufferers with EGFR-mutated non-small cell lung most cancers, together with these with poor prognostic components, remedy with Tagrisso (osimertinib) with platinum-based...

Editor

8390 POSTS
0 COMMENTS
spot_img